screening and prevention, supportive care issues, and specific populations. The NCCN Guidelines
https://www.nccn.org/guidelines/guidelines-process/development-and-update-of-guidelines• Available across 71 NCCN Guidelines, including screening and supportive care, and covering, to explore high-impact measures for endorsement, identify barriers to uptake of HRSN screening
https://www.nccn.org/docs/default-source/about/annual-report-2023.pdf?sfvrsn=8411082_31on 04/22/2024 Breast Cancer Screening and Diagnosis Panel Polygenic Risk Score, Repotrectinib Submitted by BMS on 06/14/2024 Colorectal Cancer Screening Panel
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-historyprequalified via phone screening for the Patient Assistance Program (PAP) may be eligible for up to a 30
https://www.nccn.org/docs/default-source/business-policy/rrr-pdf-2021.pdf?sfvrsn=99028107_8for low-income and uninsured patients • Patients prequalified via phone screening for the Patient
https://www.nccn.org/docs/default-source/nccn-documents/vrrrguide.pdf?sfvrsn=75e5cfc7_2of screening through long-term survivorship. These issues include: Find a Doctor, C o s t s o f C a re
https://www.nccn.org/docs/default-source/oncology-policy-program/cancer_across_life_span.pdf?sfvrsn=1b738f08_2